Evidence map›Paper›PMID 42642593›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Assay for Transposase-Accessible Chromatin Sequencing (ATAC-seq) of Cancer Cells in Culture.

Kaitlyn Gura, Trevor Long, Motoki Takaku, Archana Dhasarathy, Manu

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kaitlyn Gura *Department of Biomedical Sciences, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND, USA.
Trevor Long *Department of Biology, School of Arts and Sciences, University of North Dakota, Grand Forks, ND, USA.
Motoki TakakuDepartment of Biomedical Sciences, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND, USA. motoki.takaku@und.edu.
Archana DhasarathyDepartment of Biomedical Sciences, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND, USA. archana.dhasarathy@und.edu.
ManuDepartment of Biology, School of Arts and Sciences, University of North Dakota, Grand Forks, ND, USA. manu.manu@und.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Assay for Transposase-Accessible Chromatin followed by sequencing (ATAC-seq) is a powerful and widely-used technique for chromatin accessibility profiling due to its low input requirement, simple protocol, high sensitivity, and ability to study single cells. ATAC-seq is a powerful tool in cancer epigenetics research that has enabled the scrutiny of gene regulatory mechanisms, aided the identification of therapeutic targets, and in the exploration of anticancer immunity, thereby advancing our understanding of cancer biology. The protocol includes five main steps: cell isolation and nuclei preparation, Tn5 tagmentation, PCR amplification, library sequencing, and data analysis. Here, we have outlined a comprehensive ATAC-seq protocol that is utilized by our laboratories, along with detailed troubleshooting steps at each point, in the hopes that it will aid other researchers in utilizing this tool to the fullest capability. We also describe bioinformatics pipelines for processing the raw sequence data and identifying regulatory regions by differential accessibility analysis, as well as more advanced methods for the visualization of transcription factor binding sites.

Indexed as

ChromatinChromatin Immunoprecipitation SequencingNeoplasmsTransposasesComputational BiologyGene LibraryHigh-Throughput Nucleotide SequencingHumansSequence Analysis, DNAChromatinTn5 transposaseTransposasesATAC-seqCancerChromatin accessibilityCis-regulationTagmentationTn5 transposaseTranscription factor

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.